CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −474 | $440.16 | $209K | 36,781 |
| 2025-10-02 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion · Stock Option 10b5-1 | −11,000 | 44,000 | ||
| 2025-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,000 | $433.06 | $866K | 2,130 |
| 2025-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,000 | $436.70 | $873K | 130 |
| 2025-10-02 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 218,000 | ||
| 2025-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,080 | $423.32 | $457K | 3,050 |
| 2025-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,076 | $426.02 | $884K | 974 |
| 2025-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −844 | $426.78 | $360K | 130 |
| 2025-10-01 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 222,000 | ||
| 2025-09-30 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-09-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −4,000 | $422.84 | $1.7M | 130 |
| 2025-09-30 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 226,000 | ||
| 2025-09-29 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +14,625 | $135.42 | $2.0M | 14,625 |
| 2025-09-29 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −650 | $416.60 | $271K | 13,975 |
| 2025-09-29 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,235 | $417.52 | $516K | 12,740 |
| 2025-09-29 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −690 | $418.80 | $289K | 12,050 |
| 2025-09-29 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,327 | $419.77 | $557K | 10,723 |
| 2025-09-29 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,971 | $420.94 | $830K | 8,752 |
Page 196 of 214 · 4,273 trades